histone deacetylase inhibitor
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for histone deacetylase inhibitor, covering 2026-03-10 to 2026-03-10. Get the full timeline:
Most recent: Clinical Trial Update: Anti-PD-1 Antibody Combined With Histone Deacetylase Inhibitor in Patients With Advanced Cervical Cancer [Phase 1, Phase 2]